The goal of this study is to analyze the biological significance of the interferon system in human immunodeficiency syndrome (AIDS). In this proposal, we wish to analyze the roles which interferons play in the life cycle and pathophysiology of HIV infection and establish the efficacy of interferon therapy in AIDS disease. We have shown previously that interferon induced inhibition of murine leukemia virus (MuLV) replication occurs at the level of virus assembly and that interferon treatment leads to a formation of non-infectious particles. Our recent results show that the HIV infection in both T-cells and monocytes is sensitive to the antiviral effect of interferon. It may be anticipated that the interferon-induced block of HIV replication may not be completely identical to that seen with MuLV since the HIV replication cycle includes unique steps not seen in MuLV. In addition, we have shown recently that the infection with viruses of Herpes virus group activates the transcription of HIV and identified both the inducible sequence in the HIV-LTR and the transactivating viral protein. The present proposal is an extension of these studies and will focus on the following questions: 1) what is the role of interferon in HIV replication and HIV induced AIDS symptoms; 2) at what level of HIV replicative cycle does interferon block occur 3) can interferon inhibit HIV activation by heterologous viruses; and 4) can we, by using concepts of gene therapy, target interferon synthesis to the focus of HIV infection and thus, eliminate the toxic effects of interferon that are associated with long-term application of exogenous interferon. We believe that results of this study will allow us to evaluate in molecular terms the complex role of interferon system in human retroviral infection and will also provide a firm foundaton for the use of interferon therapy in of HIV infection in man.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026123-03
Application #
3139756
Study Section
Special Emphasis Panel (SSS)
Project Start
1988-09-01
Project End
1991-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Barnes, Betsy J; Kellum, Merrill J; Field, Ann E et al. (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 22:5721-40
Popik, W; Hesselgesser, J E; Pitha, P M (1998) Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol 72:6406-13
Popik, W; Pitha, P M (1998) Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 Virology 252:210-7
Schafer, S L; Hiscott, J; Pitha, P M (1996) Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells. Virology 224:214-23
Kunzi, M S; Pitha, P M (1996) Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication. J Interferon Cytokine Res 16:919-27
Popik, W; Pitha, P M (1996) Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway. Mol Cell Biol 16:6532-41
Schafer, S L; Vlach, J; Pitha, P M (1996) Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. J Virol 70:6937-46
Megyeri, K; Au, W C; Rosztoczy, I et al. (1995) Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol Cell Biol 15:2207-18
Kunzi, M S; Farzadegan, H; Margolick, J B et al. (1995) Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis 171:822-8
Su, Y; Popik, W; Pitha, P M (1995) Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells. J Virol 69:110-21

Showing the most recent 10 out of 29 publications